BioCentury
ARTICLE | Financial News

Inimex raises $22 million

June 3, 2008 1:31 AM UTC

Inimex (Vancouver, B.C.) raised $22 million in a series B round led by new investor Morningside Venture Investments. Roche Venture Fund; Astellas Venture Management; and Advantage Life Science Fund II, also new investors, joined existing investors BC Advantage Funds; BDC Capital; British Columbia Discovery Fund; JovInvestment Management's Canadian Medical Discovery Fund; and GrowthWorks Capital's Working Opportunity Fund in the round. ...